Aldosteronism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-08-25
Clinical Trial Update: Microvascular Function in Primary Aldosteronism
The trial NCT02096939 evaluating microvascular function in primary aldosteronism and essential hypertension has been withdrawn.